About this story
I’m honored to represent patients’ voices and help connect patients with researchers.
Yann
Diagnosed with stage IV Pancreatic Cancer at just 35, Yann reached a stage of “no evidence of disease” in 2022 against all odds.
The Rosalind Study
In 2024, Yann’s oncologist introduced him to Cure51’s Rosalind Study, a research initiative aimed at understanding why some patients, like him, achieve exceptional survival. Hoping that his own biology could help other patients experience similar progress, Yann immediately accepted to participate.
“The Rosalind Study was the first positive project I’d heard about Pancreatic Cancer in years. I was genuinely excited to contribute”
Advocating through Cure51
Yann felt inspired by Cure51’s ambitious mission, and decided to turn his journey into a source of hope for others as a Cancer survivor advocate.
Excited about the opportunity to bring his voice to a wider audience, Yann joined the Cure51 team in Paris, where he is now the manager of the patients’ committee and actively involved in discussions on patient-centered topics. He actively works on developing a patient community, meeting survivors, partnering with charities all over the world and seeking for cooperation with oncologists.
“I’m honored to represent patients’ voices and help connect patients with researchers”
Sharing hope and inspiring others
For Yann, sharing hope has become a life mission. Whether speaking in the media, taking part in webinars or participating in survivor discussions, he seeks to connect, inform and inspire. Being a survivor gave Yann the feeling his story could helpful for other people facing grim prognosis.
”When I hear other patients say my story helps them fight Cancer, it is incredibly rewarding”
